Biom Therapeutics
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Biom Therapeutics is a biopharmaceutical company that develops novel therapies for rare neurological diseases, including Angelman syndrome and epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biom Therapeutics Comparables
Compare Biom Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avata Biosciences | 83% | |
| Argent Biopharma Ltd | 82% | |
| MavriX Bio | 80% |
Biom Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 526% MoM, from 129 to 808.
- May 2, 2025
Monthly visitors grew 121% MoM, reaching 976.
Biom Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biom Therapeutics's valuation, stock price, and market status.
Is Biom Therapeutics a public or private company?
Biom Therapeutics is a private company.
What is the current stock price of Biom Therapeutics?
Biom Therapeutics is a private company with no public stock price. Caplight tracks Biom Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Biom Therapeutics worth (valuation)?
Valuation information for Biom Therapeutics is not publicly available.
Can I buy Biom Therapeutics stock?
Biom Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biom Therapeutics's last funding round?
Funding round information for Biom Therapeutics is not publicly available.
Who are the main investors in Biom Therapeutics?
Investor information for Biom Therapeutics is not publicly disclosed.
Will Biom Therapeutics IPO soon?
No public IPO plans have been announced for Biom Therapeutics.
How can I track Biom Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biom Therapeutics's secondary market activity and sign up for updates.